The FDA has granted 510(k) clearance to SleepRes’ KPAP-powered Kricket PAP device for the treatment of obstructive sleep ...

Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...

Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European ...

SleepRes, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Kricket PAP device, powered by Kairos Positive Airway Pressure (KPAP), for the treatment ...

Untreated obstructive sleep apnea accelerates cardiovascular aging and raises mortality risk in a long-term study.

Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...

Chronic sleep deprivation acts as a systemic stressor, elevating risks for cardiovascular disease and metabolic dysregulation while impairing cognitive function.